TrianglePUBLICATIONS · 35709465
Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2022 Aug 1
- First author
- Zhang Y
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Zhang Y
- type
- Author
- name
- Chen L
- type
- Author
- name
- Hu GQ
- type
- Author
- name
- Zhang N
- type
- Author
- name
- Zhu XD
- type
- Author
- name
- Yang KY
- type
- Author
- name
- Jin F
- type
- Author
- name
- Shi M
- type
- Author
- name
- Chen YP
- type
- Author
- name
- Hu WH
- type
- Author
- name
- Cheng ZB
- type
- Author
- name
- Wang SY
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Zhang Y
- type
- Author
- name
- Chen L
- type
- Author
- name
- Hu GQ
- type
- Author
- name
- Zhang N
- type
- Author
- name
- Zhu XD
- type
- Author
- name
- Yang KY
- type
- Author
- name
- Jin F
- type
- Author
- name
- Shi M
- type
- Author
- name
- Chen YP
- type
- Author
- name
- Hu WH
- type
- Author
- name
- Cheng ZB
- type
- Author
- name
- Wang SY
- type
- Author
- bibliography ids
- nci-bib-ce6c41884f1fda4dd3474f96
- book metadata
- content sha256
- 3f6077ed3443225ac6ebad9b4382ae8bb4035a18ea8999a8920bddc83e4a3f69
- document type
- citation
- dois
- 10.1200/JCO.22.00327
- electronic publication date
- display
- 2022 Jun 16
- precision
- day
- year
- 2022
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:35709465
- immutable id
- pubmed:35709465@3f6077ed3443225ac6ebad9b4382ae8bb4035a18ea8999a8920bddc83e4a3f69
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 22
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2420-2425
- volume
- 40
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 35709465
- provenance
- batch id
- 9d150d55960e0c12aada
- provider
- NCBI PubMed ESummary
- record sha256
- 23e4a23fea55c9425e61bf9bee2f930c1686ab6c0f2abfe7cffc0228f5704ae4
- response sha256
- 2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
- retrieved at
- 2026-09-09T23:48:09.820498+00:00
- publication date
- display
- 2022 Aug 1
- precision
- day
- year
- 2022
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial.
Preserved source evidence · Not medical advice